Skip to content

Insider · CIK 0001851328

Yang Rick

Reports to the SEC for 6 companies · MENLO PARK, CA

Transactions

50

Companies

6

Filings

3

CIK

0001851328

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2026-03-10KRROKorro Bio, Inc.P Purchase+$2.3M
2026-03-10KRROKorro Bio, Inc. · Pre-Funded WarrantsP Purchase+$2.7M
2026-02-09SGPSpyGlass Pharma, Inc.C Conversion—
2026-02-09SGPSpyGlass Pharma, Inc.C Conversion—
2026-02-09SGPSpyGlass Pharma, Inc.C Conversion—
2026-02-09SGPSpyGlass Pharma, Inc.C Conversion—
2026-02-09SGPSpyGlass Pharma, Inc.P Purchase+$15M
2026-02-09SGPSpyGlass Pharma, Inc. · Series B Preferred StockC Conversion—
2026-02-09SGPSpyGlass Pharma, Inc. · Series C-1 Preferred StockC Conversion—
2026-02-09SGPSpyGlass Pharma, Inc. · Series C-2 Preferred StockC Conversion—
2026-02-09SGPSpyGlass Pharma, Inc. · Series D Preferred StockC Conversion—
2025-10-02NEUENeueHealth, Inc.X Exercise of In-Money+$1,891.95
2025-10-02NEUENeueHealth, Inc.S Sale−$1,890
2025-10-02NEUENeueHealth, Inc.M Exercise/Conversion+$1,861.28
2025-10-02NEUENeueHealth, Inc.F Tax Payment−$1,863
2025-10-02NEUENeueHealth, Inc.D Disposition to Issuer—
2025-10-02NEUENeueHealth, Inc.X Exercise of In-Money+$16.6K
2025-10-02NEUENeueHealth, Inc.S Sale−$16.6K
2025-10-02NEUENeueHealth, Inc.X Exercise of In-Money+$6,075.36
2025-10-02NEUENeueHealth, Inc.S Sale−$6,075
2025-10-02NEUENeueHealth, Inc.M Exercise/Conversion+$1,240.85
2025-10-02NEUENeueHealth, Inc.F Tax Payment−$1,228.5
2025-10-02NEUENeueHealth, Inc.D Disposition to Issuer—
2025-10-02NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money—
2025-10-02NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award—
2025-10-02NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion—
2025-10-02NEUENeueHealth, Inc. · Series A Convertible Perpetual Preferred StockD Disposition to Issuer—
2025-10-02NEUENeueHealth, Inc. · Series B Convertible Perpetual Preferred StockD Disposition to Issuer—
2025-10-02NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money—
2025-10-02NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money—
2025-10-02NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award—
2025-10-02NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion—
2025-10-02NEUENeueHealth, Inc. · Series A Convertible Perpetual Preferred StockD Disposition to Issuer—
2025-10-02NEUENeueHealth, Inc. · Series B Convertible Perpetual Preferred StockD Disposition to Issuer—
2024-10-01NEUENeueHealth, Inc. · Warrant (Right to Buy)P Purchase—
2024-10-01NEUENeueHealth, Inc. · Warrant (Right to Buy)P Purchase—
2024-09-16MBXMBX Biosciences, Inc.C Conversion—
2024-09-16MBXMBX Biosciences, Inc.C Conversion—
2024-09-16MBXMBX Biosciences, Inc.P Purchase+$8M
2024-09-16MBXMBX Biosciences, Inc. · Series A Convertible Preferred StockC Conversion—
2024-09-16MBXMBX Biosciences, Inc. · Series B Convertible Preferred StockC Conversion—
2024-04-22KRROKorro Bio, Inc.P Purchase+$1M
2024-04-08NEUENeueHealth, Inc. · Warrant (Right to Buy)P Purchase—
2024-04-08NEUENeueHealth, Inc. · Warrant (Right to Buy)P Purchase—
2023-12-19NEUENeueHealth, Inc. · Warrant (Right to Buy)P Purchase—
2023-10-31NEUENeueHealth, Inc. · Warrant (Right to Buy)P Purchase—
2023-09-15NEUENeueHealth, Inc. · Warrant (Right to Buy)P Purchase—
2023-08-11NEUENeueHealth, Inc. · Warrant (Right to Buy)P Purchase—
2023-07-17SVRASavara IncP Purchase+$1M
2022-10-17NEUENeueHealth, Inc. · Series B Convertible Perpetual Preferred StockP Purchase+$37.7M